Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Other Accumulated Expenses (2019 - 2025)

Veracyte (VCYT) has disclosed Other Accumulated Expenses for 12 consecutive years, with $7000.0 as the latest value for Q1 2025.

  • Quarterly Other Accumulated Expenses fell 92.13% to $7000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $7000.0 through Mar 2025, down 92.13% year-over-year, with the annual reading at $19000.0 for FY2024, 81.19% down from the prior year.
  • Other Accumulated Expenses hit $7000.0 in Q1 2025 for Veracyte, down from $19000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $241000.0 in Q3 2021 to a low of $7000.0 in Q1 2025.
  • Historically, Other Accumulated Expenses has averaged $129800.0 across 5 years, with a median of $119000.0 in 2023.
  • Biggest five-year swings in Other Accumulated Expenses: dropped 19.48% in 2022 and later crashed 92.13% in 2025.
  • Year by year, Other Accumulated Expenses stood at $231000.0 in 2021, then decreased by 19.48% to $186000.0 in 2022, then tumbled by 45.7% to $101000.0 in 2023, then plummeted by 81.19% to $19000.0 in 2024, then tumbled by 63.16% to $7000.0 in 2025.
  • Business Quant data shows Other Accumulated Expenses for VCYT at $7000.0 in Q1 2025, $19000.0 in Q4 2024, and $53000.0 in Q3 2024.